About Immunocellular Therapy

Share：

Comparison between Immunocellular Therapy and Traditional Treatments

Treatment Name	Cancer Treatment Methods and Principles	Common Side Effects
Surgical Therapy	Surgical procedures are used to remove tissues invaded by cancer cells, targeting only "local" areas of the body. Therefore, surgically removable cancer tumors are mostly in the early stages, not yet spread or metastasized.	Surgery can easily cause bleeding and infection. The body may lose some functions after the removal of an organ. It may not completely eradicate the cancer, and there is a possibility of recurrence.
Chemotherapy	Drugs are administered through injection or oral intake to kill cancer cells or inhibit their growth. Chemotherapy is a "systemic" anti-cancer treatment that can be applied even if cancer cells have spread or metastasized. During chemotherapy, patients may experience side effects such as general weakness, nausea, vomiting, diarrhea, and hair loss.	Both cancer cells and normal cells are destroyed. There are many irreversible side effects, and the patient's quality of life (QOL) is low. Drug resistance can develop, and the effectiveness of the chemotherapy is limited to specific mutations.
Radiation Therapy	Radiation is used to target cancerous areas, killing cancer cell tissues. It is suitable for early-stage cancers that have not yet spread or metastasized and is considered a "localized" cancer treatment. The treatment is more effective when the number of cancer cells is low.	Surrounding tissues in the irradiated area may be damaged. Different sources of radiation may induce another type of cancer.
Targeted Therapy	Targeted therapy aims at specific characteristics or mechanisms of cancer cells that lead to their growth and metastasis. There are two treatment methods: oral and injectable. This therapy can precisely disrupt the genes of cancer cells and effectively prevent their proliferation, differentiation, or metastasis.	Gene testing is required to determine the presence of corresponding target genes. Drugs act only on the target, affecting both cancer cells and normal cells, and may cause irreversible side effects. Drug resistance can develop, and targeted drugs are limited to specific mutations.
Immunocellular Therapy	Immune cells are activated and expanded ex vivo and then reinfused into the patient to detect and kill cancer cells. This therapy maintains a good quality of life for cancer patients with minimal side effects. It provides long-term treatment and prevention of cancer cell recurrence. No drug resistance or rejection	This therapy has almost no side effects. only a few patients experience fever or inflammation, which helps improve the quality of life during cancer treatment. It effectively targets small cancer tissues that are hard to detect with instruments, thus preventing recurrence. No drug resistance or rejection.

Applications of immune cells

Immunocellular therapy: the fifth major cancer treatment method

Over time, chemotherapy or targeted drug treatments can lead to drug resistance in tumor cells, causing the tumors to grow again and affecting the treatment's effectiveness. Since immunocellular therapy uses the patient's own immune cells to fight cancer, it has fewer side effects, maintains the patient's quality of life, and is gradually becoming another treatment option for cancer patients.

Common Types of Immunocellular Therapy Applications

Each biotech company has its own immune cell culture techniques, each with its pros and cons. The table below lists the common immune cells and their advantages in cancer treatment：

Cell Type	Memory T cells 👍	Dendritic immune cells	Natural killer cells	Cytokine-induced killer cells (CIK)	DC-CIK	Gamma-Delta T cells (γδT /GDT cells)
Cell Culture Time	Short	Long	Short	Short	Long	Long
Invasiveness	✖️	✔️	✖️	✖️	✖️	✖️
Indications	Solid tumors	Solid tumors	Hematologic tumors	Solid tumors	Solid tumors	Solid tumors
Marketed drug	✔️	✖️	✖️	✖️	✖️	✖️
Self-proliferation ability	✔️	✖️	✖️	✖️	✖️	✖️
Specificity	High	High	Low	Low	Moderate	Moderate
Side effects	Low	Low	Low	Low	Low	Low
Characteristics	With immune specificity and long-lasting duration, memory T cells can persist in the body. Memory T cells can be reactivated and target tumor cells after cancer relapsing, reducing the risks of recurrence.	A cancer vaccine with high specificities can promote T cell activation after loading specific tumor antigens.	Innate immune cells lack specificity and are not limited by MHC.	A mixture of various types of immune cells can regulate each other and attack tumor cells collectively.	Possesses both DC and CIK cells features.	Contains the characteristics of both innate and adoptive immunity. Do not require APC dependent activation.
disadvantages	Require sophisticated cell culture techniques.	DC cells do not directly target and attack tumor cells. The tumor specific antigens are usually obtained through surgery, but if the tumor cells mutate, the antigen may no longer be effective.	NK cells are effective against hematological neoplasms but not solid tumors. A large number of cells is need to enhance the therapeutic effects.	Cell culture techniques, cell percentages (CD markers), and specificities vary between manufacturers. Cell survival period is short.	Possesses the disadvantages of both DC and CIK cells. DC cells (WT1) do not require induction through solid tumor antigens, but the effectiveness is limited depending on the patient’s condition.	GDT cells are difficult to culture, which comprise only 5% of the T cell population in health individuals and fewer in cancer patients.

Applicable Cancer Types under the Administrative Regulation on Special Medical Instruments and Inspection Techniques

免疫細胞,癌症,細胞療法,路迦生醫,癌症治療

Brain tumor, head and neck cancer, head and neck squamous cell carcinoma, nasopharyngeal carcinoma, esophageal cancer, breast cancer, non-small cell lung cancer, liver cancer, stomach cancer, pancreatic cancer, kidney cancer, colorectal cancer, cervical cancer, ovarian cancer, female peritoneal cancer

Applications for using the therapy in other types of cancer are ongoing.

Eligibility

Those deemed suitable based on blood test evaluation
The final decision for treatment must be made by a professional physician